Groundbreaking new therapies for diseases with unmet clinical need
Our mission is to develop safe and effective medicines for patients with life-threatening diseases through targeted integrin therapies
Precision integrin medicines for fibrotic diseases
Our approach is to develop a platform of novel therapeutic agents for poorly treated medical conditions by targeting complex integrin biology, through the design, chemical synthesis, and biological and clinical evaluation of potent and selective integrin antagonists.
Alevin wins Best Biotech Startup Company award at the prestigious OBN Awards 2022